MNOV Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
458.4K
+145.2%
187.0K
+23.2%
151.7K
+23.0%
123.3K
-8.4%
134.6K
Cost of Revenue
0
0
0
0
0
Gross Profit
458.4K
+145.2%
187.0K
+23.2%
151.7K
+23.0%
123.3K
-8.4%
134.6K
Operating Expenses
3.0M
-0.8%
3.0M
-6.8%
3.2M
-7.4%
3.5M
-6.3%
3.7M
R&D
1.0M
-18.5%
1.3M
-18.2%
1.5M
-2.5%
1.6M
-27.7%
2.2M
SG&A
2.0M
+11.9%
1.8M
+3.5%
1.7M
-11.5%
1.9M
+23.7%
1.6M
Operating Income
-2541189
+10.4%
-2835806
+8.3%
-3092402
+8.5%
-3380998
+6.3%
-3607092
EBITDA
-2536169
+10.4%
-2831546
+8.3%
-3087847
+8.5%
-3375695
+6.3%
-3602028
Net Income
-2314139
+10.5%
-2586258
+7.7%
-2802279
+8.1%
-3050373
+7.0%
-3281185
EPS (Basic)
$-0.05
+0.0%
$-0.05
+16.7%
$-0.06
+0.0%
$-0.06
+14.3%
$-0.07
EPS (Diluted)
$-0.05
+0.0%
$-0.05
+16.7%
$-0.06
+0.0%
$-0.06
+14.3%
$-0.07
Shares (Diluted)
49.2M
+0.0%
49.2M
+0.2%
49.1M
+0.1%
49.0M
+0.0%
49.0M
Medicinova (MNOV) โ€” Financials